The FDG-PET Revolution of Medical Imaging – Four Decades and Beyond

Title:The FDG-PET Revolution of Medical Imaging – Four Decades and Beyond

Volume: 4 Issue: 1

Author(s): Soren Hess, Sandip Basu, Bjorn A. Blomberg, Marnix Lam, Mateen C. Moghbel, Hongyun J. Zhu, Siroos Mirzaei, Abass Alavi and Poul F. Hoilund-Carlsen

Affiliation:

Keywords: FDG, PET, PET/CT, PET/MRI, cardiology, clinical drug development, infection, inflammation, pediatrics, neurology psychiatry, oncology, radiation therapy planning.

Abstract: The use of 2-deoxy-2-[¹⁸F] fluoro-D-glucose (FDG) and positron emission tomography/ computed tomography (PET/CT) is increasing rapidly – and the list of emerging and evolving applications is everexpanding in a multitude of clinical settings. In this anniversary review celebrating four decades of FDG, we will outline an overview of the present status of FDG imaging with emphasis on clinical implementation in the main indications of FDG-PET/CT, i.e. neurology and psychiatry, oncology, cardiovascular diseases, and infectious and inflammatory diseases, including some general considerations towards clinical benefit and potential future directions.

Cite this article as:

Hess Soren, Basu Sandip, A. Blomberg Bjorn, Lam Marnix, C. Moghbel Mateen, J. Zhu Hongyun, Mirzaei Siroos, Alavi Abass and Hoilund-Carlsen Poul F., The FDG-PET Revolution of Medical Imaging – Four Decades and Beyond, Current Molecular Imaging (Discontinued) 2015; 4 (1) . https://dx.doi.org/10.2174/2211555204666150710175824

DOI https://dx.doi.org/10.2174/2211555204666150710175824	Print ISSN 2211-5552
Publisher Name Bentham Science Publisher	Online ISSN 2211-5544